Most cited article(s)

You have access
¹⁷⁷Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
Amir Karimzadeh, Matthias Heck, Robert Tauber, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher

Journal of Nuclear Medicine March 1, 2023, 64 (3) 402-409; DOI: https://doi.org/10.2967/jnumed.122.264402
You have access
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of ⁸⁹Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
Michael D. Farwell, Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn, Alessandro Mascioni, William Le, Ian Wilson, Michael S. Gordon, Anna M. Wu, Gary A. Ulaner, Jedd D. Wolchok, Michael A. Postow and Neeta Pandit-Taskar

Journal of Nuclear Medicine May 1, 2022, 63 (5) 720-726; DOI: https://doi.org/10.2967/jnumed.121.262485
Open Access
Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review
Philipp T. Meyer, Sabine Hellwig, Ganna Blazhenets and Jonas A. Hosp

Journal of Nuclear Medicine July 1, 2022, 63 (7) 971-980; DOI: https://doi.org/10.2967/jnumed.121.263085
Open Access
Correlation of ⁶⁸Ga-FAPi-46 PET Biodistribution with FAP Expression by Immunohistochemistry in Patients with Solid Cancers: Interim Analysis of a Prospective Translational Exploratory Study
Christine E. Mona, Matthias R. Benz, Firas Hikmat, Tristan R. Grogan, Katharina Lueckerath, Aria Razmaria, Rana Riahi, Roger Slavik, Mark D. Girgis, Giuseppe Carlucci, Kimberly A. Kelly, Samuel W. French, Johannes Czernin, David W. Dawson and Jeremie Calais

Journal of Nuclear Medicine July 1, 2022, 63 (7) 1021-1026; DOI: https://doi.org/10.2967/jnumed.121.262426
You have access
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
George Sgouros, Yuni K. Dewaraja, Freddy Escorcia, Stephen A. Graves, Thomas A. Hope, Amir Iravani, Neeta Pandit-Taskar, Babak Saboury, Sara St. James and Pat B. Zanzonico

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 12S-22S; DOI: https://doi.org/10.2967/jnumed.121.262750
You have access
Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with ¹⁷⁷Lu-PSMA Therapy: A Multicenter Retrospective Analysis
Masatoshi Hotta, Andrei Gafita, Johannes Czernin and Jeremie Calais

Journal of Nuclear Medicine October 1, 2022, 63 (10) 1484-1488; DOI: https://doi.org/10.2967/jnumed.121.263441
You have access
Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources
Jacek Capala, Stephen A. Graves, Aaron Scott, George Sgouros, Sara St. James, Pat Zanzonico and Brian E. Zimmerman

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 3S-11S; DOI: https://doi.org/10.2967/jnumed.121.262749
You have access
To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy
Sandy Srinivas and Andrei Iagaru

Journal of Nuclear Medicine November 1, 2021, 62 (11) 1487-1488; DOI: https://doi.org/10.2967/jnumed.121.263035
You have access
Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel

Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972
You have access
Impact of ¹⁸F-FET PET/MRI on Clinical Management of Brain Tumor Patients
Cornelia Brendle, Caroline Maier, Benjamin Bender, Jens Schittenhelm, Frank Paulsen, Mirjam Renovanz, Constantin Roder, Salvador Castaneda-Vega, Ghazaleh Tabatabai, Ulrike Ernemann and Christian la Fougère

Journal of Nuclear Medicine April 1, 2022, 63 (4) 522-527; DOI: https://doi.org/10.2967/jnumed.121.262051

Main menu

User menu

Search

Most cited article(s)

Pages